Genea Biocells promotes awareness and funding for Friends of FSH Research.
Facioscapulohumeral Dystrophy (FSHD) affects hundreds of thousands of people worldwide with progressive loss of skeletal muscle strength affecting mainly the face, arms and legs. Scientists have only recently elucidated the pathogenesis that leads to this skeletal muscle weakness but much more research is needed toward therapies.
Genea Biocells were the first in the world to derive FSHD affected human pluripotent stem cells, turn them into skeletal muscle and show FSHD-related phenotypes that can now be leveraged for drug screening campaigns (http://doi.org/10.5966/sctm.2015-0224).
To promote awareness for FSHD, the Genea Biocells staff developed the Myotube Mike figurines (pictured herein) and distributed them at the International Society for Stem Cell Research (ISSCR) annual meeting. With each post, like, or share of a photo of Myotube Mike that includes the hashtag #MyotubeMike4FSHD on Facebook/Instagram/Twitter, Genea Biocells will donate to support the incredible mission of Friends of FSH Research, a non-profit organization focused on accelerating treatments or cures for the disease. For more information, please visit http://geneabiocells.com and http://www.fshfriends.org.